Latest California Healthline Stories
Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
Watch: Big Medicaid Changes in California Leave Millions of Patients Behind
California Healthline senior correspondent Angela Hart discusses how California’s big Medicaid experiment to bring social services to the sickest and costliest patients doesn’t help most patients.
Employers Use Patient Assistance Programs to Offset Their Own Costs
Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.
Florida Leaders Misrepresented Research Before Ban on Gender-Affirming Care
The Florida policy backed by Gov. Ron DeSantis relies on one key statistic that many experts question.
Assisted Living Facilities Pressed to Address Growing Needs of Older, Sicker Residents
Assisted living was meant to be a home-like setting where older adults could interact with other residents while receiving help with daily tasks such as bathing and dressing. But as the concept has become more popular, residents are now older and sicker than in the past, and a panel of experts is calling for more focus on their medical and mental health needs.
Much of the CDC Is Working Remotely. That Could Make Changing the Agency Difficult.
Like many U.S. workplaces, the Centers for Disease Control and Prevention went remote during the pandemic. Most of the agency’s staff members haven’t returned to the office full time, raising concerns about the CDC’s ability to reform itself after recent stumbles.
Watch: The Politics of Health Care in California
California Healthline senior correspondent Angela Hart discussed the most pressing health care issues in California with the nonpartisan group Democracy Winters in mid-November, touching on a variety of issues, from the state’s effort to transform its Medicaid program to its plan to produce generic insulin.
The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
KHN’s ‘What the Health?’: Medicaid Machinations
The lame-duck Congress has returned to Washington with a long health care to-do list and only a little time. Meanwhile, some of the states that have not yet expanded Medicaid eligibility under the Affordable Care Act are rethinking those decisions. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews KHN’s Fred Clasen-Kelly, who reported and wrote the latest KHN-NPR “Bill of the Month” feature, about a mysterious mishap during minor surgery.
Addiction Treatment Proponents Urge Rural Clinicians to Pitch In by Prescribing Medication
The number of U.S. health care providers certified to prescribe buprenorphine more than doubled in the past four years, and treatment advocates hope to see that trend continue.